БЛОГ

Apr 4, 2020

Trial drug can significantly block early stages of COVID-19 in engineered human tissues

Posted by in category: biotech/medical

An international team led by University of British Columbia researcher Dr. Josef Penninger has found a trial drug that effectively blocks the cellular door SARS-CoV-2 uses to infect its hosts.

The findings, published today in Cell, hold promise as a treatment capable of stopping early infection of the novel coronavirus that, as of April 2, has affected more than 981,000 people and claimed the lives of 50,000 people worldwide.

Comments are closed.